account_id none on file
legal_name Azenta, Inc.
ticker AZTA
cik 933974
domain azenta.com
linkedin_company_url https://www.linkedin.com/company/azenta-life-sciences
entry_point_account_id none on file
name Azenta Inc.
exchange Nasdaq
sector Technology
hq Burlington, MA, United States
sector index/company/sector/technology/
calls 0 filings 60 executives 4 family 0
why_now
approximately $6 million, reflecting continued investment in automation, capacity expansion, and technology to support scalable growth. Turning to guidance on slide 8, we are referring our guidance for fiscal 2026 with organic revenue growth
May 27, 2026 / receipt
callsnone on file
filings
Client Coordinator | {"ats": "workday", "city": "US - Plainfield", "state": "IN", "job_id": "/job/US---Plainfield-IN/Client-Coordinator_R20260585", "remote": false, "category": "other", "function": "o
company_statement / Sep 15, 2026 / receipt
Clinical Project Manager I | {"ats": "workday", "city": "US - Plainfield", "state": "IN", "job_id": "/job/US---Plainfield-IN/Clinical-Project-Manager-I_R20260586", "remote": false, "category": "other"
company_statement / Sep 15, 2026 / receipt
Sr. Administrative Assistant, SRS | {"ats": "workday", "city": "US - Plainfield", "state": "IN", "job_id": "/job/US---Plainfield-IN/Sr-Administrative-Assistant--SRS_R20260593-1", "remote": false, "cat
company_statement / Sep 15, 2026 / receipt
Associate Scientist I, M-F, 8AM - 4PM EST | {"ats": "workday", "city": "US - South Plainfield", "state": "NJ", "job_id": "/job/US---South-Plainfield-NJ/Associate-Scientist-I--M-F--8AM---4PM-EST_R20260
company_statement / Sep 15, 2026 / receipt
Business and Quality Analyst | {"ats": "workday", "city": "US - South Plainfield", "state": "NJ", "job_id": "/job/US---South-Plainfield-NJ/Business-and-Quality-Analyst_R20260494", "remote": false, "ca
company_statement / Sep 15, 2026 / receipt
Completed the sale of B Medical Systems on July 1, 2026, further aligning the portfolio with our strategic priorities
ir_statement / Sep 15, 2026 / receipt
Q4 FY26 organic revenue is expected to decline LSD, consistent with prior guidance primarily due to a difficult comparison versus Q4’25, particularly in Multiomics
ir_statement / Sep 15, 2026 / receipt
Returned $50 million of capital via 2.3 million share repurchases
ir_statement / Sep 15, 2026 / receipt
Transformation costs represent expenses associated with discrete strategic initiatives undertaken to simplify, standardize, streamline, and optimize the Company's operations, processes, and systems.
ir_statement / Sep 15, 2026 / receipt
Transformation costs represent expenses associated with discrete strategic initiatives undertaken to simplify, standardize, streamline, and optimize the Company's operations, processes, and systems.
ir_statement / Sep 15, 2026 / receipt
Including UKBC: Margin down ~160 bps to down 120 bps YoY
ir_statement / Sep 15, 2026 / receipt
Including UKBC: Margin down ~160 bps to down 35 bps YoY
ir_statement / Sep 15, 2026 / receipt
executives
| Ephraim Starr | Senior Vice President | - | receipt |
| Herman Cueto | Executive Vice President and Chief Financial Officer | - | receipt |
| John Marotta | President and Chief Executive Officer | - | receipt |
| Lawrence Lin | Executive Vice President & Chief Financial Officer | receipt |
familynone on file
upcoming
changes
| 2026-04-07 | President, departed | sec_8k |
| 2025-05-16 | Senior Vice President, appointed | sec_8k |
| 2024-11-12 | Executive Vice President and Chief Financial Officer, appointed | sec_8k |
| 2024-09-04 | President and Chief Executive Officer, appointed | sec_8k |
| 2023-09-26 | Executive Vice President and Chief Financial Officer, appointed | sec_8k |
mcp_package_hint
slug azenta-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$